Intensive chemotherapy in children with stage IV neuroblastoma

Indian Journal of Pediatrics

Volumn 66, Issue 6, 1999, Pages 867-872

  Kusumakumari, P ^a,b   Ajithkumar, T V ^a   Hariharan, S ^b   Varma, R R ^b   Chellam, V G ^b   Nair, Rekha ^a   Nair, M Krishnan ^a  

^a REGIONAL CANCER CENTRE   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Chemotherapy; Neuroblastoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE;

ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROBLASTOMA; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 0032758318     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02723857     Document Type: Article

References (25)

1. Evans AE, D' Angio GJ, Koop CE. The role of multimodal therapy in patients with local and regional neuroblastoma. J Paed Surg 1984; 19: 77-80.
2. Mathey KK, Sather HN, Seeger RC, Haase GM, Hammand GD. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 1989; 7: 236-244.
3. Nischke R, Smith El, Shochat S et al. Localised neuroblastoma treated by surgery. A POG study. J Clin Oncol 1988; 6: 1271-1279.
4. Haase GM, Wang Ky, De Lorimier AA et al. Improvement in survival after excision of primary in stage III neuroblastoma. J Paed Surg 1989; 24: 194-200.
5. West DC, Shamberger RC, Macklis RM et al. Stage III neuroblastoma more than 1 year of age at diagnosis. Improved survival with intensive multimodality treatment including multiple alkylating agents. J Clin Oncol 1993; 11: 84-90.
6. Ikeda K, Nakagawara A, Huromichi Y et al. Improved survival rates in children more than one year with stage II and IV neuroblastoma following intensive chemotherapy regimen. J Paed Surg 1989; 24: 189-193.
7. Green AA, Hayes FA, Hustu HO. Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with neuroblastoma. Cancer 1981; 48: 2310-2317.
8. Hayes FA, Green AA, Casper J et al. Clinical evaluation of sequentially scheduled cisplatin and VM-26 in neuroblastoma. Response and toxicity. Cancer 1981; 48: 1715-1718.
9. Green AA, Hayes FA, Casper J et al. Extended disease-free-survival for patients with disseminated neuroblastoma treated with cyclophosphamide, adriamycin, cisplatin and VM-26. Proc Am Asso Cancer Res 1983; 241-268.
10. Brodeur GM, Seeger RC, Barett A et al. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol 1988; 6: 1874-1881.
11. Williams NB. Hayes Fa, Green AA et al. Cyclophosphamide/doxorubicin vs cisplatin/etoposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: A POG randomized phase II study. Med Ped Oncol 1995; 24: 176-180.
12. Miller AB, Hoogstraten B, Staquet M, Winker AA. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
13. Kushner BH, La Quaglia MP, Bonilla MA et al. Aggressive multimodality induction therapy of stage IV neuroblastoma in children over 1 year of age. Preliminary results. Proc Am Soc Clin Oncol 1992; 11: 367.
14. Shafford EA, Roger DW, Pritchard J. Advanced neuroblastoma, improved response rate using multiagent regimen (OPEC) including sequential cisplatin and VM-26. J Clin Oncol 1984; 2: 742-746.
15. Dini G, Lanino E, Garavanta A et al. Myeloablative therapy and unpurged autologous bone marrow transplant for poor prognosis neuroblastoma. Report of 34 cases. J Clin Oncol 1991; 9: 963-269.
16. Shuster JJ, Cantor AB, Mc Williams N et al. The prognostic significance of autologous bone marrow transplantation in advanced neuroblastoma. J Clin Oncol 1991; 9: 1045-1049.
17. Cheung N, Heller G. CT dose intensity correlates strongly with response, median survival and median progression free survival in metastatic neuroblastoma. J Clin Oncol 1991; 9: 1050-1058.
18. Sitarz A, Finkelstein J, Grosseld J et al. An evaluation of the role of surgery in disseminated neuroblastoma. A report from CCSG. J Paed Surg 1983; 18: 147-151.
19. Matsumura M, Atkinson JB, Hay DM et al. An evaluation of role of surgery in metastatic neuroblastoma. J Ped Surg 1988; 23: 448-453.
20. Shamberger RD, Allarde-Segundo A, Kozakewich HPW, Grier HE. Surgical management of stage III and IV neuroblastoma-resection before or after CT. J Ped Surg 1991; 26: 1113-1118.
21. Ogita S, Tokiwa K, Majima S. An evaluation of surgical treatment and CT of advanced neuroblastoma with special reference to proliferation kinetics of residual tumors. J Ped Surg 1985; 20: 150-154.
22. Gorelik E, Segal E, Shapiro J, Katzev S, Rony Feldman M. Interaction between the local tumour and its metastasis. Cancer Metast Rev 1982; 1: 83-84.
23. Befthold F, Trechow R, Utsch S et al. Prognostic factors in metastatic neuroblastomas. Am J Ped Hematol Oncol 1992; 14: 207-215.
24. Stram DO, Malthay KK, O Leary M, Reynolds CP, Seeger RC. Myeloablative chemoradiotherapy vs continued CT for high risk neuroblastoma. Proc Clin Biol Res 1994; 385: 287-291.
25. Shuster JJ, Cantor AB, Mc Williams N et al. The prognostic significance of autologous bone marrow transplantation in advanced neuroblastoma. J Clin Oncol 1991; 9: 1045-1049.